Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 349341 - 349360 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Norway | (M05BA06) ibandronic acid | Bondronat 50 mg | 28 stk, Blisterpakning, Tablett, filmdrasjert, 50 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Hypercalcemia; Breast Neoplasms; Neoplasm Metastasis; Fractures, Bone | AtnahsPharmaNetherlandsB.V. |
| Norway | (M05BA06) ibandronic acid | Bondronat 50 mg | 84 stk, Blisterpakning, Tablett, filmdrasjert, 50 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Hypercalcemia; Breast Neoplasms; Neoplasm Metastasis; Fractures, Bone | AtnahsPharmaNetherlandsB.V. |
| Norway | (M05BA07) risedronic acid | Optinate Septimum 35 mg | 12 stk, Blisterpakning, Tablett, filmdrasjert, 35 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
n/a | OrifarmAS |
| Norway | (M05BA08) zoledronic acid | Zoledronic acid Actavis 4 mg/5 ml | 5 ml, Hetteglass av plast, Konsentrat til infusjonsvæske, oppløsning, 4 mg/5 ml , Hetteglass av plast | Retail price with vat |
$0-0 |
$0-0 |
Fractures, Bone | ActavisGroupPTCehf(2) |
| Norway | (M05BA08) zoledronic acid | Zoledronsyre Hospira 4 mg/100 ml | 1 x 100 ml, Pose, Infusjonsvæske, oppløsning, 4 mg/100 ml , Pose | Retail price with vat |
$0-0 |
$0-0 |
Hypercalcemia | PfizerEuropeMAEEIG(1) |
| Norway | (M05BC01) dibotermin alfa | InductOs 1,5 mg/ml | , sett, Pulver, væske og matriks til matriks til implantasjon, 1,5 mg/ml , sett | Retail price with vat |
$0-0 |
$0-0 |
Tibial Fractures; Fracture Fixation, Internal; Spinal Fusion | MedTronicBioPharmaB.V. |
| Norway | (M05BX06) romosozumab | Evenity 105 mg | 2 x 105 mg, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 105 mg , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Osteoporosis | UCBPharmaS.A.(2) |
| Norway | (M05BX07) vosoritide | Voxzogo 0,4 mg | , Hetteglass, Pulver og væske til injeksjonsvæske, oppløsning, 0,4 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Achondroplasia | BioMarinInternationalLimited |
| Norway | (M05BX07) vosoritide | Voxzogo 0,56 mg | , Hetteglass, Pulver og væske til injeksjonsvæske, oppløsning, 0,56 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Achondroplasia | BioMarinInternationalLimited |
| Norway | (M05BX07) vosoritide | Voxzogo 1,2 mg | , Hetteglass, Pulver og væske til injeksjonsvæske, oppløsning, 1,2 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Achondroplasia | BioMarinInternationalLimited |
| Norway | (M09AX03) ataluren | Translarna 1 000 mg | 30 x 1 stk, Dosepose, Granulat til mikstur, suspensjon, 1 000 mg , Dosepose | Retail price with vat |
$0-0 |
$0-0 |
Muscular Dystrophy, Duchenne | PTCTherapeuticsInternationalLimited |
| Norway | (M09AX03) ataluren | Translarna 125 mg | 30 x 1 stk, Dosepose, Granulat til mikstur, suspensjon, 125 mg , Dosepose | Retail price with vat |
$0-0 |
$0-0 |
Muscular Dystrophy, Duchenne | PTCTherapeuticsInternationalLimited |
| Norway | (M09AX03) ataluren | Translarna 250 mg | 30 x 1 stk, Dosepose, Granulat til mikstur, suspensjon, 250 mg , Dosepose | Retail price with vat |
$0-0 |
$0-0 |
Muscular Dystrophy, Duchenne | PTCTherapeuticsInternationalLimited |
| Norway | (M09AX09) onasemnogene abeparvovec | Zolgensma 2x10 E13 vektorgenomer/ml | 9 x 8.300000000000001 ml, Hetteglass, Infusjonsvæske, oppløsning, 2x10 E13 vektorgenomer/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited |
| Norway | (M09AX09) onasemnogene abeparvovec | Zolgensma 2x10 E13 vektorgenomer/ml | 10 x 8.300000000000001 ml, Hetteglass, Infusjonsvæske, oppløsning, 2x10 E13 vektorgenomer/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited |
| Norway | (M09AX09) onasemnogene abeparvovec | Zolgensma 2x10 E13 vektorgenomer/ml | 11 x 8.300000000000001 ml, Hetteglass, Infusjonsvæske, oppløsning, 2x10 E13 vektorgenomer/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited |
| Norway | (M09AX09) onasemnogene abeparvovec | Zolgensma 2x10 E13 vektorgenomer/ml | 3 x 8.300000000000001 ml, Hetteglass, Infusjonsvæske, oppløsning, 2x10 E13 vektorgenomer/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited |
| Norway | (M09AX09) onasemnogene abeparvovec | Zolgensma 2x10 E13 vektorgenomer/ml | 2 x 8.300000000000001 ml, Hetteglass, Infusjonsvæske, oppløsning, 2x10 E13 vektorgenomer/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited |
| Norway | (M09AX09) onasemnogene abeparvovec | Zolgensma 2x10 E13 vektorgenomer/ml | , Hetteglass, Infusjonsvæske, oppløsning, 2x10 E13 vektorgenomer/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited |
| Norway | (M09AX09) onasemnogene abeparvovec | Zolgensma 2x10 E13 vektorgenomer/ml | , Hetteglass, Infusjonsvæske, oppløsning, 2x10 E13 vektorgenomer/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Muscular Atrophy, Spinal | NovartisEuropharmLimited |
Pages
